Le Pr Jean-Christophe BERNHARD (coordinateur national) et le Pr Pierre BIGOT (coordinateur national-adjoint) du réseau @UroCCR sont ravis d’accueillir les participants de cette 7ème édition.
Thank you to everyone for being part of #IKCSEU26! 🧡🌟🔬
Your contributions and collaboration make this community so impactful.
🗓️ Be sure to save the date for #IKCSNA26 in Dallas this November! #kidneycancer@OncoAlert
At #EAU26, during the @EAUYAUrology meeting, the Best Abstract by a YAU Group is presented by @GaelleMargue 🇫🇷Bordeaux
Highlighting outstanding research and innovation from the next generation of academic urologists.
Thank you to everyone who attended today’s webinar 🙏🏻
A truly insightful session, with excellent updates shared by an outstanding faculty.
Great content, great interaction, and a very engaged audience 👏👏
UROwebinar Alert
Locally advanced renal cancer – Surgical challenges
📅 11 Nov 25
🕢 18:30
Top faculty from ESU, EAU & YAU will cover complex RCC surgery, caval thrombus management, and the role of neo/adjuvant therapy
🔗 Register via MyEAU
@UrowebESU
The Malouf Lab at IGBMC (Strasbourg, France) is recruiting a postdoctoral researcher to join a translational research program focused on rare and treatment-resistant kidney cancers.
🔗 Full details here: https://t.co/0Hupu6AnUK
Let’s build something meaningful @SPBassociation
1/ Recently, our lab has worked with outstanding groups (#TeamScience) to address some key questions in kidney cancer immunobiology:
Can we use machine-learning approaches to classify RCC and predict response? @Cancer_Cell
What drives exceptional response with immunotherapies? @NatureCancer
How do specific immune populations, like NK cells, change in advanced disease? @ESMO_Open
How does CD8+ T cell phenotype impact response to anti-PD1 treatment? @CD_AACR
Why does chromophobe kidney cancer seemingly have lower responses to immune checkpoint inhibitors? @JCO_ASCO
What are immunologically relevant antigen classes in RCC (specifically, ERVs)? @CellCellPress
Can we therapeutically target tumor-specific antigens in kidney cancer? @Nature
The best outcomes of kidney tumour resections are observed for patients treated at higher-volume hospitals. Is it time to change the @CUS_CLS_JEP rules for CZ? #uroczech https://t.co/EFHLdEy2W8
Productive first meeting of the new YAU RCC team!
Projects assigned, ideas flowing, collaborations set in motion💡🤝🏻
Ready to tackle the key challenges in RCC research — together 💪🏻
@eau_yuo@Uroweb
7 robotic surgical platforms. Live cases. The best in robotic urology. Welcome to ERUS25!
📍 London, 10-12 September, 2025
📌Registration & abstract submission now open!
🚀 Live surgery, case discussions, industry sessions and more!
🔗 Join us: https://t.co/ywfaTXOn6J
🤖Can AR enhance robotic surgery for complex urology surgery?
🎯 Case @#EAU25:
✅ Radical nephrectomy + IVC thrombectomy
✅ 3D model overlay + automated tracking
✅ Improved view of thrombus & lumbar veins
🎥 https://t.co/AwY2jwha1i
#Urology#RoboticSurgery#AR@uroccr@Uroweb
🔬 #EAU25 – Jour 3 : Les faits marquants ! 🔬
💡 Rein :
🇫🇷 La France brille au #UroCCR avec 13 abstracts !
📊 Dépistage du CCR : acceptabilité élevée (96,1 % sans regret), coût-efficace et 1/50 cancers détectés.
🛠 Lithiase :
💨 Aspiration > mesure du volume des fragments ? Débat relancé !
🆕 Glitz et CVAC en test : révolution ou complications ?
🔬 Prostate :
🚫 TRANSLATE : fin actée de la voie transrectale pour les biopsies.
🎯 OPTIMUM : microUS ≈ IRM pour détecter les CaP cliniquement significatifs.
📉 ARNEO : ajout d’apalutamide en néoadjuvant ? Pas d’impact majeur.
🔥 Urothélial :
🦠 ctDNA pré-cystectomie : biomarqueur clé de la récidive !
🔪 Curage ganglionnaire maximal essentiel pour le pronostic. Robot vs ouvert = pas de différence.
🦠 Infectiologie :
💊 APPEAL trial : prophylaxie antibiotique en ESWL ? Cipro ↓ urosepsis (0 vs 1,2 %, p=0.003), mais pas d’impact sur ITU symptomatiques.
➡️ #Urology #MedTwitter
@FUTUR_AFU@Uroweb@MRoupret
Day 3 at #EAU25 was all about kidney cancer: 🩺 screening, surgical techniques, 🤖 technological innovation, 🧪 biomarkers, and 🧩 complex cases. A deep dive into challenges and progress!
Now time to gather with friends and enjoy the night in Madrid!
@Uroweb@AFUrologie@uroccr
Very grateful for the opportunity to present results of multicentric CAVORISK study (UroCCR 174) at #EAU2025 !
Left-sided renal tumors with IVC thrombus are associated to an increase risk of hemodialysis after surgery. @AlexIngels@uroccr@afufuro@AFUrologie
Day 2 at #EAU25
🤖Presented AR-guided robot-assisted nephrectomy + IVC thrombectomy (@CHUBordeaux)
🧠“Urology made simple” during YUOR Day—great way to clarify complex topics
💊Cabozantinib remains effective post-IO (Controversies in GU cancer)
Great science, great sessions!